Phylogenetic Groups and Antimicrobial Resistance among Uropathogenic Escherichia coli Isolates from Hospitalized Patients in Tehran
Novelty in Biomedicine,
Vol. 13 No. 3 (2025),
27 July 2025
,
Page 135-143
https://doi.org/10.22037/nbm.v13i3.40353
Abstract
Background: The presence of Escherichia coli among uropathogens is increasing significantly worldwide. It accounts for a considerable amount of morbidity and high medical costs and also can lead to mortality. The current research aims to investigate E. coli antimicrobial susceptibility patterns and the molecular causes of E. coli resistance trends and virulence factors among phylogenetic groups of Uropathogenic Escherichia coli (UPEC) in Urinary tract infection (UTI) patients in a hospital in Tehran, Iran. The antimicrobial susceptibility of urinary E. coli isolates.
Materials and Methods: The antimicrobial susceptibility of urinary E. coli isolates was tested using the Kirby-Bauer agar disc diffusion method. In addition, resistance and virulence genes were monitored by polymerase chain reaction (PCR), and the clonal relation of isolates was studied by pulsed-field gel electrophoresis (PFGE).
Results: Studied isolates showed the highest susceptibility rates to MEM (95.7%), followed by TZP (90%). In contrast, resistance rates were found for AMP (100%), SXT (74%), and CIP (51.5%). ESBL-producing isolates were positive for blaTEM, blaCTX-M, and blaSHV by PCR, respectively. According to the adhesion gene analyses, fimH (85.8%) was the most prevalent among E. coli isolates, followed by aer (49.7%), hlyA (46.1%), and pap (38.9%). A total of 57 PFGE patterns and three clusters (A–C) were identified by the PFGE method. (cluster A: Non-ESBL & Sensitive to all Antibiotics use; Cluster B: The most common cluster in terms of TEM, CTX-M, or both; Cluster C: containing CTX-M gene and resistant to ceftriaxone and ciprofloxacin).
Conclusion: Our data showed ESBL rates were high in UTI E. coli isolated in the studied hospital. The UPEC isolates exhibited a high resistance rate to first- and second-generation cephalosporins and fluoroquinolone, which could result in serious public health risks. The relationship between virulence factors and resistance genes is complex and needs more studies specific to each area.
- E. coli
- Virulence
- Resistance
- Urine tract infection
- PFGE
How to Cite
References
Momtaz H, Karimian A, Madani M, Safarpoor Dehkordi F, Ranjbar R, Sarshar M, et al. 2013, Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties. Annals of clinical microbiology and antimicrobials.12:8.
Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clinical microbiology reviews 1991; 4(1):80-128.
Ponnusamy P, Nagappan R, editors. 2013. Extended Spectrum Beta -Lactamase, Biofilm-producing Uropathogenic Pathogens and Their Antibiotic Susceptibility Patterns from Urinary Tract Infection- An Overview.
Rashedmarandi F, Rahnamayefarzami M, Saremi M, Sabouri R. 2008. A Survey On Urinary Pathogens and Their Antimicrobial Susceptibility Among Patients with Significant Bacteriuria. Iranian Journal of Pathology. 3(4):191-6.
Azami M, Jaafari Z, Masoumi M, Shohani M, Badfar G, Mahmudi L, et al. 2019. The etiology and prevalence of urinary tract infection and asymptomatic bacteriuria in pregnant women in Iran: a systematic review and Meta-analysis. BMC urology. 19(1):43.
Totsika M, Moriel DG, Idris A, Rogers BA, Wurpel DJ, Phan MD, et al. 2012. Uropathogenic Escherichia coli mediated urinary tract infection. Current drug targets. 13(11):1386-99.
Raza S, Pandey S, Bhatt CP. 2011. Microbiological analysis of isolates in Kathmandu Medical College Teaching Hospital, Kathmandu, Nepal. Kathmandu University medical journal (KUMJ). 9(36):295-7.
Kargar M, Zarei Y, Amini A, Ghasemi M. Detection of ESBL-producing uropathogenic E. coli in Jiroft city, Iran. Jundishapur J Microbiol. 2023;16(1):e132211. doi:10.5812/jjm-132211.
Nouri R, Rahbar M, Alizade H, Asadi A. Molecular detection of ESBL genes in uropathogenic E. coli from northern Iran. Iran J Microbiol. 2022;14(3):285–91.
Firoozeh F, Khorshidi A, Khazaei H. Antimicrobial resistance and prevalence of ESBL genes in E. coli from UTI in Rafsanjan, Iran. Jundishapur J Microbiol. 2021;14(6):e114273. doi:10.5812/jjm.114273.
Basak S, Singh R, Rajurkar M. Global prevalence of ESBL-producing Escherichia coli: a systematic review and meta-analysis. J Glob Antimicrob Resist. 2024;29:151–9.
Peirano G, Pitout JD. 2010. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. International journal of antimicrobial agents. 35(4):316-21.
Bashir S, Haque A, Sarwar Y, Ali A, Anwar MI. 2012. Virulence profile of different phylogenetic groups of locally isolated community acquired uropathogenic E. coli from Faisalabad region of Pakistan. Annals of clinical microbiology and antimicrobials. 11:23.
Johnson JR, Russo TA. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. International journal of medical microbiology : IJMM.; 295(6-7):383-404.
Wang Y, Zhao S, Han L, Guo X, Chen M, Ni Y, et al. 2014. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. The Journal of antibiotics. 67(12):799-805.
Heidary M, Momtaz H, Madani M. 2014. Characterization of Diarrheagenic Antimicrobial Resistant Escherichia coli Isolated from Pediatric Patients in Tehran, Iran. Iranian Red Crescent medical journal. 16(4):e12329.
http://www.Pulsenetinternational.org
Ranjbar R, Pezeshknejad P, Khamesipour F, Amini K, Kheiri R. 2017. Genomic fingerprints of Escherichia coli strains isolated from surface water in Alborz province, Iran. BMC Research Notes. 10(1):295.
Raeispour M, Ranjbar R. 2018. Antibiotic resistance, virulence factors and genotyping of Uropathogenic Escherichia coli strains. Antimicrobial resistance and infection control. 7:118.
Sabat AJ, Budimir A, Nashev D, Sá-Leão R, van Dijl J, Laurent F, et al. 2013. Overview of molecular typing methods for outbreak detection and epidemiological surveillance. Euro surveillance. 18(4):20380.
van Belkum A, Tassios PT, Dijkshoorn L, Haeggman S, Cookson B, Fry NK, et al. 2007. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 13 Suppl 3:1-46.
Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing, 32nd edition. CLSI supplement M100. Wayne, PA: CLSI; 2022.
Weinstein MP. 2019. Performance Standards for Antimicrobial Susceptibility Testing. Thirtieth, editor: CLSI; 332 p.
Farshad S, Emamghorashi F. 2009. The prevalence of virulence genes of E. coli strains isolated from children with urinary tract infection. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 20(4):613-7.
Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zerouali K, et al. 2011. Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. Journal of medical microbiology. 60(Pt 9):1344-52.
Dolatyar Dehkharghani A, Haghighat S, Rahnamaye-Farzami M, Douraghi M, Rahbar M. 2021. Subtyping β-lactamase-producing Escherichia coli strains isolated from patients with UTI by MLVA and PFGE methods. Iranian Journal of Basic Medical Sciences. 24(4):437-43.
Ejrnaes K, Stegger M, Reisner A, Ferry S, Monsen T, Holm SE, et al. Characteristics of Escherichia coli causing recurrent urinary tract infections: genomic diversity and relation to strain persistence and virulence gene content. Clin Microbiol Infect. 2006;12(1):78–86.
Dong H-J, Lee S, Kim W, An J-U, Kim J, Kim D, et al. 2017. Prevalence, virulence potential, and pulsed-field gel electrophoresis profiling of Shiga toxin-producing Escherichia coli strains from cattle. Gut Pathogens. 9(1):22.
Hojabri Z, Ahmadi A, Gholami M, et al. High prevalence of multidrug-resistant Escherichia coli in clinical samples from Iran. Front Cell Infect Microbiol. 2023;13:1129417.
Antimicrobial Resistance Pattern of Escherichia coli Isolated From Patients With Urinary Tract Infection in Tehran, Iran in 2021. ResearchGate. 2023.
World Health Organization. GLASS Report: Global Antimicrobial Resistance and Use Surveillance System. 2023. Available from: https://www.who.int/glass
Hooton TM, Gupta K, James W, et al. Resistance patterns in community-onset urinary tract infection: findings from the EMBARK global surveillance program. Clin Infect Dis. 2021;72(5):836–44. doi:10.1093/cid/ciaa1476.
Wang Y, Zhao S, Han L, Guo X, Chen M, Ni Y, et al. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China. J Antibiot. 2014;67:799–805.
Tarchouna M, Ferjani A, Ben-Selma W, Boukadida J. 2013. Distribution of uropathogenic virulence genes in Escherichia coli isolated from patients with urinary tract infection. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 17(6):e450-3.
Wiles TJ, Kulesus RR, Mulvey MA. 2008. Origins and virulence mechanisms of uropathogenic Escherichia coli. Experimental and molecular pathology. 85(1):11-9.
Watabe M, Hogg GM, Millar BC, Crothers L, Rooney PJ, Loughrey A, et al. 2008. Epidemiological study of E. coli O157:H7 isolated in Northern Ireland using pulsed-field gel electrophoresis (PFGE). The Ulster medical journal. 77(3):168-74.
Maluta RP, Borges CA, Beraldo LG, Cardozo MV, Voorwald FA, Santana AM, et al. 2014. Frequencies of virulence genes and pulse field gel electrophoresis fingerprints in Escherichia coli isolates from canine pyometra. Veterinary journal (London, England: 1997). 202(2):393-5.
Anvarinejad M, Farshad S, Ranjbar R, Giammanco GM, Alborzi A, Japoni A. 2012. Genotypic Analysis of E. coli Strains Isolated from Patients with Cystitis and Pyelonephritis. Iranian Red Crescent medical journal. 14(7):408-16.
Ejrnaes K, Sandvang D, Lundgren B, Ferry S, Holm S, Monsen T, et al. 2006. Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women. Journal of clinical microbiology. 44(5):1776-81.
Dolatyar Dehkharghani A, Haghighat S, Rahnamaye Farzami M, Rahbar M, Douraghi M. 2021. Clonal Relationship and Resistance Profiles Among ESBL-Producing Escherichia coli. Frontiers in Cellular and Infection Microbiology. 11(499).
Jones TF, Sashti N, Ingram A, Phan Q, Booth H, Rounds J, et al. 2016. Characteristics of Clusters of Salmonella and Escherichia coli O157 Detected by Pulsed-Field Gel Electrophoresis that Predict Identification of Outbreaks. Foodborne pathogens and disease. 13(12):674-8.
Cao X, Zhang Z, Shen H, Ning M, Chen J, Wei H, et al. 2014. Genotypic characteristics of multidrug-resistant Escherichia coli isolates associated with urinary tract infections. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica. 122(11):1088-95.
Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A. 2002. Phylogenetic Background and Virulence Profiles of Fluoroquinolone-Resistant Clinical Escherichia coli Isolates from The Netherlands. The Journal of Infectious Diseases. 186(12):1852-6.
Soto SM, Smithson A, Martinez JA, Horcajada JP, Mensa J, Vila J. 2007. Biofilm formation in uropathogenic Escherichia coli strains: relationship with prostatitis, urovirulence factors and antimicrobial resistance. The Journal of urology. 177(1):365-8.
- Abstract Viewed: 112 times
- pdf Downloaded: 75 times